KR20170118758A - 방부 효과가 있는 의약의 조합 - Google Patents

방부 효과가 있는 의약의 조합 Download PDF

Info

Publication number
KR20170118758A
KR20170118758A KR1020177023489A KR20177023489A KR20170118758A KR 20170118758 A KR20170118758 A KR 20170118758A KR 1020177023489 A KR1020177023489 A KR 1020177023489A KR 20177023489 A KR20177023489 A KR 20177023489A KR 20170118758 A KR20170118758 A KR 20170118758A
Authority
KR
South Korea
Prior art keywords
salt
pharmaceutical composition
less
preservative
test sample
Prior art date
Application number
KR1020177023489A
Other languages
English (en)
Korean (ko)
Inventor
다카시 모리모토
나오키 마츠모토
겐지 오키
히로유키 아사다
다카시 츠보이
Original Assignee
산텐 세이야꾸 가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 산텐 세이야꾸 가부시키가이샤 filed Critical 산텐 세이야꾸 가부시키가이샤
Publication of KR20170118758A publication Critical patent/KR20170118758A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/382—Heterocyclic compounds having sulfur as a ring hetero atom having six-membered rings, e.g. thioxanthenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
KR1020177023489A 2015-02-23 2016-02-22 방부 효과가 있는 의약의 조합 KR20170118758A (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2015032655 2015-02-23
JPJP-P-2015-032655 2015-02-23
JP2015116705 2015-06-09
JPJP-P-2015-116705 2015-06-09
PCT/JP2016/054976 WO2016136642A1 (fr) 2015-02-23 2016-02-22 Combinaison de médicaments ayant un effet antiseptique

Publications (1)

Publication Number Publication Date
KR20170118758A true KR20170118758A (ko) 2017-10-25

Family

ID=55541236

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020177023489A KR20170118758A (ko) 2015-02-23 2016-02-22 방부 효과가 있는 의약의 조합

Country Status (5)

Country Link
JP (3) JP5893204B1 (fr)
KR (1) KR20170118758A (fr)
RU (1) RU2017130858A (fr)
TW (1) TW201636014A (fr)
WO (1) WO2016136642A1 (fr)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RO113612B1 (ro) * 1991-04-17 1998-09-30 Merck & Co Inc Compozitie oftalmica
FR2918891B1 (fr) * 2007-07-20 2009-09-25 Thea Sa Lab Solution ophtalmique a base de prostaglandines sans conservateur
KR20100076967A (ko) * 2007-09-07 2010-07-06 리실 인터내셔널 리미티드 파트너쉽 계량식 액적 푸시 버튼 분배기 시스템
TW201109325A (en) * 2009-07-30 2011-03-16 Wakamoto Pharma Co Ltd Aqueous composition for eye drops

Also Published As

Publication number Publication date
JP2016106115A (ja) 2016-06-16
JP6877613B2 (ja) 2021-05-26
JP2016216439A (ja) 2016-12-22
RU2017130858A3 (fr) 2019-07-29
TW201636014A (zh) 2016-10-16
JP5893204B1 (ja) 2016-03-23
WO2016136642A1 (fr) 2016-09-01
RU2017130858A (ru) 2019-03-25
JP6707365B2 (ja) 2020-06-10
JP2020128422A (ja) 2020-08-27

Similar Documents

Publication Publication Date Title
JP6903448B2 (ja) ドルゾラミドとブリモニジンを含む医薬組成物
KR102491425B1 (ko) 에피나스틴 함유 점안액
JP6178028B1 (ja) ドルゾラミドとチモロールと界面活性剤を含有する医薬組成物
JP2023093601A (ja) 眼科用製品
JP6877613B2 (ja) 防腐効果のある医薬の組合せ
JP6877196B2 (ja) メグルミン又はその塩からなる防腐剤
JP6702754B2 (ja) ドルゾラミドを含有する防腐剤
WO2017057434A1 (fr) Composition aqueuse pharmaceutique
JP2022173166A (ja) エピナスチン含有点眼液
JP2022123792A (ja) 水性医薬組成物
JP2018070582A (ja) エピナスチン含有点眼液